months after irradiation, and on whom insufficient data were available, 90 patients were included. For these 90 patients, we analysed the exophthalmometry, ductions, soft tissue signs and visual acuity shortly before irradiation and after 3 and 6 months, respectively.
The measurements of the ductions showed an improvement of both abduction (p = 0.05) and elevation (p = 0.02) of about 1° after 3 months. Virtually no further change occurred between 3 and 6 months follow-up (Fig. 1) . We separately analysed the data of the 14 patients who showed a restricted motility of more than 10° in one or more directions. After 3 months their mean abduction had improved by 4° (p = 0.009), and their mean elevation also by 4° (p = 0_02). Also in this group, we virtually f ound no further change at 6 months follow-up (Fig. 2) .
The numerical analysis of the soft tissue signs showed an average score of 1.0 (SD 0.7) before irradiation and of 0.8 (SD 0.8, P = 0.6) at 3 months thereafter. At 6 months after irradiation the average score had improved to 0.6 (SD 0.6, P = 0.1). Table 2 summarises the NOSPECS score.
The visual acuity was on average 0.92 both before irradiation and at follow-up.
Discussion
Our data reveal no effect of retrobulbar irradiation on exophthalmos. Even in patients with a large amount of exophthalmos -in whom more effect might theoretically be expected -no reduction in exophthalmos could be An improvement in soft tissue signs was noted only after 6 months. In the above-mentioned follow-up study by Perros et az. 14 spontaneous improvement in the soft tissue signs was noted after 3-6 months. Therefore, the improvement we found after irradiation cannot be differentiated from the natural history of the disease. 14 Table 2 . Average NOSPECS score, standard deviation and p value according to the classification system presented in Table 1 , shortly before irradiation and at 3 and 6 months follow-up In conclusion, patients with severely restricted eye motility in Graves' ophthalmopathy probably benefit from retrobulbar irradiation. It does not seem to be indicated to treat exophthalmos. Because we excluded patients with signs of malignant Graves' ophthalmopathy and patients in whom another intervention was performed, we have no information on the effect of irradiation in this group. To better identify which patients might benefit from retrobulbar irradiation, a prospective randomised study is needed.
